drugset
Drugs / Prophylactic Plasma Transfusion
last change Apr 2024 re-read 3 minutes ago

Prophylactic Plasma Transfusion

Developed for
leptospirosis
Investigated by
Department of Science and Technology, Philippines · Institute of Human Genetics, National Institutes of Health - University of the Philippines Manila, Philippines · National Kidney and Transplant Institute, Philippines · San Lazaro Hospital, Philippines

Trials 1

today NCT07127718 · Ph 2
202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT07127718 Apr 2024 → Mar 2027 expected leptospirosis National Kidney and Transplant Institute, Philippines Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Prophylactic Plasma Transfusion ClinicalTrials.gov intervention name — accepted as the source's own label NCT07127718 ↗
Action Restore “the program will look into the possibility of CFI repletion using plasma transfusion” NCT07127718 ↗
Route Intravenous “Plasma transfusion will be administered intravenously” NCT07127718 ↗